Chiome Bioscience is a Japanese biopharmaceutical venture company focused on antibody drug discovery and development targeting high unmet medical needs, including cancers such as hepatocellular carcinoma and diseases such as ALS and Alzheimer's. The company operates two core business segments: a Drug Discovery business, which generates proprietary antibody drug candidates using its ADLib® system and out-licenses them to pharmaceutical companies for upfront fees, milestones, and royalties; and a Drug Discovery Support business, which provides antibody and protein production services, affinity maturation, and related contract research services to pharma, diagnostics companies, and academic institutions. Its competitive strengths include a proprietary antibody generation technology platform (ADLib® system), an integrated capability from lead discovery through early-stage clinical development, and a specialized human network enabling efficient resource acquisition.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →Chiome Bioscience is a Japanese biopharmaceutical venture company focused on antibody drug discovery and development targeting high unmet medical needs, including cancers such as hepatocellular carcinoma and diseases such as ALS and Alzheimer's. The company operates two core business segments: a Drug Discovery business, which generates proprietary antibody drug candidates using its ADLib® system and out-licenses them to pharmaceutical companies for upfront fees, milestones, and royalties; and a Drug Discovery Support business, which provides antibody and protein production services, affinity maturation, and related contract research services to pharma, diagnostics companies, and academic institutions. Its competitive strengths include a proprietary antibody generation technology platform (ADLib® system), an integrated capability from lead discovery through early-stage clinical development, and a specialized human network enabling efficient resource acquisition.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →